On February 26, Washington, D.C. life sciences and health care partner Bill McConagha spoke during ACI’s “Advanced Legal, Regulatory and Compliance Forum on Over the Counter Drugs.” Mr. McConagha spoke during a session titled “OTC Drug Imports: Manufacturing and Labeling Best Practices To Avoid Detentions and Rejections at the Border.” Topics included vetting product labels and advertising claims, forecasting why the U.S. Food and Drug Administration may block product entry, and complying with current good manufacturing practices.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates